Postmenopausal breast cancer: Risk, symptoms, and more

Link
MHT and breast cancer
Other risk factors
Contacting a doctor
FAQ
Postmenopausal breast cancer occurs at higher rates due to cumulative hormone exposure and age-related cellular changes that increase cancer risk.
Breast cancer develops when cells in breast tissue begin to grow and divide uncontrollably, forming tumors that can spread to other parts of the body.
The risk of breast cancer increases significantly with age, particularly after menopause, when hormonal and cellular changes create an environment more conducive to cancer development.
This article explores postmenopausal breast cancer risk, symptoms to watch for, and risk reduction strategies following menopause. Curly_photo/Getty Images
Yes, the risk of breast cancer can increase after menopause. Statistics show that the likelihood of developing breast cancer rises with age, with about 1 in 8 women developing the disease during their lifetime, and the majority of these cases occurring after menopause.
In those ages 20 to 24, there are 1.5 breast cancer cases per 100,000. This figure jumps to more than 421 cases in those ages 75 to 79. More than 9 in 10 new female breast cancer cases occur in those ages 40 or over.
This age-related increase means that postmenopausal people may benefit from regular screening.
The relationship between breast cancer and menopause centers on the length of hormone exposure.
During reproductive years, the body produces estrogen and progesterone every month as part of the menstrual cycle. These hormones signal breast cells to grow and divide, a process that is entirely natural.
However, each time cells divide, there is a slight chance for mistakes to occur in the DNA. Over many years, these mistakes can accumulate and potentially lead to cancer development.
While menopause itself does not directly cause cancer, breast cancer risk naturally increases with age. Those who experience menopause later in life, after age 55, have a higher risk of breast cancer because their bodies were exposed to reproductive hormones for longer periods.
Menopausal hormone therapy (MHT) is another consideration. Many people use MHT during perimenopause to manage symptoms such as hot flashes, but some types of MHT increase breast cancer risk. The risk appears to be higher with combined estrogen and progesterone treatment compared to estrogen alone.
MHT can increase breast cancer risk, but the level of risk depends on the specific type of HRT used.
Combination MHT, which contains both estrogen and progesterone, poses a higher risk than estrogen-only therapy. Estrogen-only MHT is typically used by those who have had hysterectomies. It does not appear to be linked to an increased breast cancer risk, making it a safer option for appropriate candidates.
MHT may increase the initial risk of developing breast cancer and make it more likely that cancer will be detected at advanced stages.
According to Breastcancer.org, this occurs partly because combination MHT increases breast density, making mammograms less effective at spotting early cancers. The risk appears greater with daily progesterone use compared to less frequent dosing schedules.
The dose and duration of MHT also play a significant role in breast cancer risk. Higher doses carry a greater risk than lower doses, and this increased risk can persist for more than 10 years after treatment stops. These findings apply to both synthetic hormones and bioidentical products, despite marketing claims that natural hormones are safer.
Anyone considering MHT should discuss their risk factors with healthcare professionals to weigh the benefits of symptom relief against potential cancer risks. Reproductive history : Never having children or having a first child after age 30 increases the risk. Pregnancy lowers breast cell exposure to circulating estrogen. The more children a person has, the greater the protection against breast cancer.
: Never having children or having a first child after age 30 increases the risk. Pregnancy lowers breast cell exposure to circulating estrogen. The more children a person has, the greater the protection against breast cancer. Lifestyle factors : A lack of physical activity and excessive alcohol consumption can contribute to increased risk. Smoking, particularly if started at a young age, also elevates breast cancer risk.
: A lack of physical activity and excessive alcohol consumption can contribute to increased risk. Smoking, particularly if started at a young age, also elevates breast cancer risk. Medical factors : Previous breast biopsies showing atypical cells, family history of breast or ovarian cancer, and genetic mutations such as BRCA1 or BRCA2 significantly increase risk. Radiation exposure to the chest area, particularly during adolescence, also contributes to elevated risk.
: Previous breast biopsies showing atypical cells, family history of breast or ovarian cancer, and genetic mutations such as BRCA1 or BRCA2 significantly increase risk. Radiation exposure to the chest area, particularly during adolescence, also contributes to elevated risk. Dense breast tissue: Dense breast tissue has a higher risk of developing breast cancer and may require additional screening methods beyond standard mammography. Maintain a moderate weight : Working toward and maintaining a moderate weight through balanced nutrition and regular physical activity significantly reduces risk.
: Working toward and maintaining a moderate weight through balanced nutrition and regular physical activity significantly reduces risk. Exercise regularly : Aim for at least 150 minutes of moderate-intensity aerobic activity per week, plus two sessions of strength training exercises each week.
: Aim for at least 150 minutes of moderate-intensity aerobic activity per week, plus two sessions of strength training exercises each week. Limit alcohol consumption : Restrict alcohol intake to no more than one drink per day, as alcohol consumption is linked to increased breast cancer risk at any level of intake.
: Restrict alcohol intake to no more than one drink per day, as alcohol consumption is linked to increased breast cancer risk at any level of intake. Follow screening guidelines : Adhere to the recommended mammography schedules, typically once or twice a year, depending on age and risk factors. People with a higher risk may need additional screening methods.
: Adhere to the recommended mammography schedules, typically once or twice a year, depending on age and risk factors. People with a higher risk may need additional screening methods. Consider preventive medications: For high risk individuals, medications like tamoxifen or raloxifene may reduce breast cancer risk by around 40% . These decisions require careful discussion with oncologists or breast specialists.
A person should contact a doctor if they notice any symptoms of breast cancer.
Postmenopausal individuals should be particularly vigilant because they no longer experience monthly breast changes related to menstrual cycles, making new abnormalities more significant. Any persistent change lasting more than 2 weeks warrants medical evaluation.
Although regular self-examinations are not a replacement for professional screening, they can help people become familiar with their normal breast tissue and detect changes early.
Invasive ductal carcinoma (IDC) accounts for about 80% of breast cancer cases and breast cancer mainly develops in those around the age of 62.
Generally, yes. After menopause, the body produces much less estrogen and progesterone, the hormones that many breast cancers depend on to grow and spread. With lower hormone levels after menopause, these cancers receive weaker growth signals and tend to develop more slowly. This hormonal change creates a less favorable environment for cancer growth compared to the higher hormone levels present during reproductive years.
Yes, postmenopausal breast cancer is typically less aggressive. Many breast cancers in older individuals are 'hormone-receptor-positive,' meaning they have receptors that allow hormones to fuel their growth.
These hormone-positive cancers respond well to treatments that block hormones or prevent the body from making them, essentially cutting off the cancer's fuel supply.
Postmenopausal breast cancer risk increases significantly with age. The relationship between menopause and breast cancer stems from cumulative hormonal exposure and age-related cellular changes.
Risk factors include MHT, excess weight, family history, and lifestyle factors. People can reduce their risk by maintaining a moderate weight, engaging in regular exercise, limiting alcohol consumption, and following screening guidelines.
While postmenopausal breast cancers are often hormone receptor-positive and slower-growing, early detection remains crucial for optimal outcomes. Symptoms may be subtle but include new lumps, breast changes, and nipple abnormalities.
Breast Cancer
Menopause
Cancer / Oncology

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Daily Mail​

16 minutes ago

• Daily Mail​

Every newborn baby in the UK will have DNA screening in NHS 'revolution' to battle killer diseases, Wes Streeting reveals

Every newborn baby in the UK will have a DNA screening as part of an NHS 'revolution' to battle killer diseases. The health secretary Wes Streeting said new technology in areas such as genomics would help 'leapfrog' illnesses. The Government is set to pour £650 million into DNA technology in an effort to treat serious illnesses before they become a problem. The investment in genomics is expected to support the Government's 10-year plan for the NHS, which will see a greater focus on technology and prevention. Mr Streeting told The Telegraph: 'The revolution in medical science means that we can transform the NHS over the coming decade, from a service which diagnoses and treats ill health to one that predicts and prevents it. 'Genomics presents us with the opportunity to leapfrog disease, so we're in front of it rather than reacting to it.' Mr Streeting has previously spoken about his desire to make the NHS more preventative, reducing rates of serious illness and saving money in the process. The plan is also likely to see a greater role for artificial intelligence and other technologies to predict illness and allow treatment or medication to be offered much earlier. Mr Streeting has previously spoken about his desire to make the NHS more preventative, reducing rates of serious illness and saving money in the process. The plan is also likely to see a greater role for artificial intelligence and other technologies to predict illness and allow treatment or medication to be offered much earlier. He added: 'With the power of this new technology, patients will be able to receive personalised healthcare to prevent ill health before symptoms begin, reducing the pressure on NHS services and helping people live longer, healthier lives.' Along with a greater focus on prevention, the Government's 10-year plan is expected to include Mr Streeting's two other 'shifts' in the NHS. That will see a shift away from hospitals towards more community-focused care, and from analogue to digital services. It follows Chancellor Rachel Reeves' announcement that the Government would increase NHS funding by £29 billion per year in real terms over the next three years as it tries to cut waiting lists in line with its election promises.

The Independent

24 minutes ago

• The Independent

Popular children's cough medicine recalled over potentially deadly bacterial infection risk

A popular cough medicine for children has been recalled over a risk of bacterial infection that can be deadly. Little Remedies Honey Cough Syrup was recalled Tuesday over the 'presence' of Bacillus cereus, a type of bacteria that can cause two types of foodborne illnesses, and because of 'loss of shelf-stability,' according to a notice from the medicine makers, Medtech Products Inc. The recall describes the symptoms associated with both foodborne illnesses. One can cause nausea, vomiting and stomach cramps starting one to six hours after consuming contaminated food. The second illness can cause stomach cramps and diarrhea starting 8 to 16 hours after exposure. 'Although healthy individuals may suffer only short-term illness, exposure to high levels of foodborne B. cereus can cause death,' the recall notice warned. No serious adverse effects have been reported as of the date of the recall. The recalled cough syrup was sold by retailers throughout the country and online from December 14, 2022, to June 4, 2025. Consumers with the recalled medicine are advised to stop using it immediately and contact their doctor if they experience any symptoms that may be related to the product. The company is also offering a refund of the product.

The Guardian

40 minutes ago

• The Guardian

All babies in England to get DNA test to assess risk of diseases within 10 years

Every baby in England is to have a DNA screening to avoid fatal diseases and receive personalised healthcare as part of the government's £650m investment in DNA technology, it has been reported. Within a decade, every newborn will undergo whole genome sequencing, which assesses the risk of hundreds of diseases and is expected to form part of the government's 10-year plan for the health service. Wes Streeting, the health secretary, told the Telegraph the advances in genomics would allow people to 'leapfrog' killer illnesses and receive 'personalised' health care. He said: 'The revolution in medical science means that we can transform the NHS over the coming decade, from a service which diagnoses and treats ill health to one that predicts and prevents it. 'Genomics presents us with the opportunity to leapfrog disease, so we're in front of it rather than reacting to it.' Streeting added: 'With the power of this new technology, patients will be able to receive personalised healthcare to prevent ill health before symptoms begin, reducing the pressure on NHS services and helping people live longer, healthier lives.' All new parents are now offered a blood spot test for their babies, normally when the child is five days old, to check whether they have any of nine rare but serious conditions. The newborn's heel is pricked to collect a few drops of blood on a card that is sent away to be tested. Along with a greater focus on prevention, the 10-year plan is expected to include Streeting's other 'shifts' in the NHS, from hospitals towards more community-focused care and from analogue to digital services. Last week the chancellor, Rachel Reeves, announced that the government would increase NHS funding by £29bn a year in real terms over the next three years. A Department of Health and Social Care spokesperson said: 'Our 10-year health plan will be published soon and will set out details for a range of initiatives to advance the NHS and make it fit for the future.' In October, the NHS in England announced it was to screen 100,000 newborn babies for more than 200 genetic conditions in a world-first scheme aimed at bolstering early diagnosis and treatment.